FindTrial
Sign In

A General Clinical Pharmacological Study of TRK-820 Soft Capsules - Refractory Pruritus in Patients on Peritoneal Dialysis-

A General Clinical Pharmacological Study of TRK-820 Soft Capsules - Refractory Pruritus in Patients on Peritoneal Dialysis-

Status
Unknown
Phases
Phase 3
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT2080222514
Enrollment
Unknown
Registered
2014-06-05
Start date
2014-06-05
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intractable Pruritus in Patients on Peritoneal Dialysis

Interventions

investigational material(s) Generic name etc : TRK-820 INN of investigational material : Nalfurafine Hydrochloride Therapeutic category code : 119 Other agents affecting central nervous system Dosage

Sponsors

Toray Industries,Inc.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1)Patients on Peritoneal Dialysis (2)It can be confirmed that the treatment of pruritus with existing therapies such as antihistamines or antiallergics has not been adequately effective in such patients

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Changes in the VAS values—

Secondary

MeasureTime frame
Changes in the VAS values, Changes in the itching scores, Mean VAS values, Mean itching scores, VAS improvement degree—

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026